Covered recipient · General Payments record
BRADLEY SCOTT FLETCHER
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,863.34
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $861.13 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| bluebird bio, Inc. | $499.68 | 5 |
| Agios Pharmaceuticals, Inc. | $124.95 | 1 |
| Rigel Pharmaceuticals, Inc. | $114.06 | 1 |
| GENZYME CORPORATION | $90.06 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.72 | 1 |
| Teva Pharmaceuticals USA, Inc. | $15.66 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $124.95 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149646448 | CMS |
| bluebird bio, Inc. | $141.53 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095479315 | CMS |
| bluebird bio, Inc. | $32.17 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095479317 | CMS |
| bluebird bio, Inc. | $125.94 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095479319 | CMS |
| bluebird bio, Inc. | $108.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095479321 | CMS |
| bluebird bio, Inc. | $92.04 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095479323 | CMS |
| GENZYME CORPORATION | $90.06 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139930819 | CMS |
| Novartis Pharmaceuticals Corporation | $16.72 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086959603 | CMS |
| Rigel Pharmaceuticals, Inc. | $114.06 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145199625 | CMS |
| Teva Pharmaceuticals USA, Inc. | $15.66 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151559722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.